IP Verse

Pharmaceutical Composition, Methods For Treating And Uses Thereof

Patent No. EP3539540 (titled "Pharmaceutical Composition, Methods For Treating And Uses Thereof") was filed by Boehringer Ingelheim on Nov 7, 2011. The application was issued on Dec 18, 2024.

Patent Summary

A pharmaceutical composition for preventing, treating, or reducing the risk of hypoglycemia in patients with diabetes, comprising an SGLT2 inhibitor and an insulin, administered in combination or alternation. The composition is particularly effective in patients with type 1 diabetes, where it can reduce the risk of hypoglycemia and improve glycemic control. The SGLT2 inhibitor works by inhibiting glucose reabsorption in the kidneys, while the insulin provides glucose-lowering effects. The combination of the two can prolong the duration of insulin efficacy, reduce the required insulin dose, and prevent or delay the progression of diabetes complications.

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR REDDYS LABORATORIES UK BETAPHARM ARZNEIMITTELSep 18, 2025MAIWALD
ELENDSep 18, 2025JOHNSON
GENERICS UKSep 18, 2025TER MEER STEINMEISTER & PARTNER
SANDOZSep 18, 2025ELKINGTON AND FIFE
STADA ARZNEIMITTELSep 18, 2025KERNEBECK
POLPHARMASep 17, 2025ELKINGTON AND FIFE
HAMM & WITTKOPPSep 16, 2025HAMM & WITTKOPP
WUESTHOFF & WUESTHOFFSep 16, 2025SONNENHAUSER
CAMULONSep 15, 2025REDDIE & GROSE
TEVA PHARMACEUTICALSSep 12, 2025KRAUS & LEDERER PARTGMBB
BARDEHLE PAGENBERGSep 10, 2025BARDEHLE PAGENBERG SL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3539540

BOEHRINGER INGELHEIM
Application Number
EP19163940A
Filing Date
Nov 7, 2011
Status
Granted And Under Opposition
Nov 15, 2024
Publication Date
Dec 18, 2024
External Links
Slate, Register , Google Patents